Oropharyngeal absorption of atropine.
The oropharyngeal absorption of atropine was studied following 0.02, 0.04, 0.06 and 0.07 mg/kg doses of the drug to pregnant patients at term and compared with a 0.02 mg/kg dose given either intramuscularly or subcutaneously. The rate of systemic drug absorption was comparable following the two parenteral drug injections, but oropharyngeal atropine administration is of minor clinical significance.
D000042:Absorption; D000284:Administration, Oral; D000328:Adult; D001285:Atropine / Q000097:blood*; D001682:Biological Availability; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D009060:Mouth Floor; D009061:Mouth Mucosa / Q000378:metabolism*; D010614:Pharynx / Q000378:metabolism*; D011247:Pregnancy / Q000097:blood*
D001285:Atropine